Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACZ885 for abdominal aortic aneurysm
NL-OMON38947Phase 2Active, not recruiting
- Sponsor
- Novartis
- Start
- Feb 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of canakinumab in abdominal aortic aneurysm (AAA), sponsored by Novartis. Started Feb 2014; status: active, not recruiting.
02
Drugs
canakinumab
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NL-OMON38947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38947.